Evidence map›Paper›PMID 40259105›Full record

ArticleMikrochimica acta2025

A ruthenium-nickel metal-organic framework incorporating 2,2'-bipyridine- 5,5'-dicarboxylic acid for dual-mode electrochemiluminescence-fluorescence detection of ferric ions.

Jing Zhang, Zhaojiang Yin, Wei Xiong, QiQi Fan, Fengyao Yu, Fusheng Liao, Hao Fan, Fei Qu, Qiangqiang Yu

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing Zhang *Department of Pharmacy and the Affiliated Hospital, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Zhaojiang Yin *Clinical Medical Research Center, Yichun People's Hospital, Yichun, China.
Wei XiongDepartment of Pharmacy and the Affiliated Hospital, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
QiQi FanDepartment of Pharmacy and the Affiliated Hospital, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Fengyao YuSchool of Medicine, Qilu University of Technology, Jinan, Shandong, China.
Fusheng LiaoDepartment of Pharmacy and the Affiliated Hospital, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.
Hao FanDepartment of Pharmacy and the Affiliated Hospital, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China. fanhao11@aliyun.com.
Fei QuDepartment of Pharmacy and the Affiliated Hospital, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China. quf0917@163.com.
Qiangqiang YuDepartment of Pharmacy and the Affiliated Hospital, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China. 461951825@qq.com.

Funding

Jiangxi Provincial Key Laboratory of Effective Material Basis of TCM 2024SSY07102Jiangxi University of Chinese Medicine School-level Science and Technology Innovation Team Development Program CXTD22005National Science Foundation of China 81872968Science and technology project of Education Department of Jiangxi Province GJJ180654the Natural Science Foundation of Jiangxi Province 20192BAB205103 20212ACB206005
6 · The paper itself

Abstract

A novel, low-toxicity Ru-Ni-BPY metal-organic framework (MOF) nanomaterial was developed and a simple and sensitive dual-mode "on-off" ferric ions (Fe

Indexed as

2,2'-DipyridylElectrochemical TechniquesIronLuminescent MeasurementsMetal-Organic FrameworksNickelRutheniumAnimalsLimit of DetectionMiceMice, NudeRatsSpectrometry, Fluorescence2,2'-DipyridylIronMetal-Organic FrameworksNickelRutheniumDual-mode detectionFe3+ detectionIn vivo imagingRu-Ni-BPY MOF

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.